Virchow Drugs Profile
Key Indicators
- Authorised Capital ₹ 32.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 12.24 Cr
as on 24-10-2024
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.41 Cr
as on 24-10-2024
- Revenue 7.14%
(FY 2023)
- Profit 12.99%
(FY 2023)
- Ebitda 12.20%
(FY 2023)
- Net Worth 18.09%
(FY 2023)
- Total Assets 14.25%
(FY 2023)
About Virchow Drugs
The Corporate was formerly known as Virchow Drugs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 32.50 Cr and a paid-up capital of Rs 12.24 Cr.
The company currently has active open charges totaling ₹12.41 Cr.
The Key Managerial Personnel (KMP) at Virchow Drugs Limited India are Pamidi Ravindra as CFO and Monika Bhutada as Company Secretary. Sudha Mundla, Narayana Mundla, Ravindra Kutagulla, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PLC042949
- Company No.
042949
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2004
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Virchow Drugs?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pamidi Ravindra | CFO | 01-Apr-2021 | Current |
| Monika Bhutada | Company Secretary | 23-Apr-2019 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudha Mundla  | Director | 31-Mar-2009 | Current |
| Narayana Mundla | Director | 25-Mar-2004 | Current |
| Ravindra Kutagulla | Director | 21-Mar-2018 | Current |
| Lingareddy Venkata | Director | 31-Mar-2009 | Current |
| Nandigala Reddy | Director | 31-Mar-2009 | Current |
| Prasanth Nandigala | Director | 12-Sep-2007 | Current |
Financial Performance and Corporate Structure Insights of Virchow Drugs.
Virchow Drugs Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.14% increase. The company also saw a substantial improvement in profitability, with a 12.99% increase in profit. The company's net worth Soared by an impressive increase of 18.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Virchow Drugs?
In 2021, Virchow Drugs had a promoter holding of 97.35% and a public holding of 2.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mukunda Dairy Products Private LimitedActive 22 years 10 monthsLingareddy Venkata is a mutual person
Virchow Petrochemical Private LimitedActive 21 years 6 monthsSudha Mundla, Narayana Mundla and 3 more are mutual person
- Andhra Organics LimitedActive 33 years 10 months
Sudha Mundla, Narayana Mundla and 2 more are mutual person
- Virchow Laboratories LimitedActive 42 years 10 months
Sudha Mundla, Narayana Mundla and 5 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 22 Sep 2005 | ₹12.41 Cr | Open |
How Many Employees Work at Virchow Drugs?
Virchow Drugs has a workforce of 109 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Virchow Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Virchow Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
